Selamectin (Revolution)

Selamectin, marketed under the brand name Revolution, is a macrocyclic lactone antiparasitic medication that has become widely used for treating lice and mite infestations in guinea pigs. This topical spot-on formulation provides systemic antiparasitic activity through transdermal absorption, offering a convenient and effective treatment option for ectoparasite control. Originally developed for dogs and cats, selamectin has been extensively used off-label in guinea pigs and other exotic small mammals with excellent results and a well-established safety profile. Exotic veterinarians frequently choose selamectin as a first-line treatment for guinea pig lice due to its ease of application and reliable efficacy.

The mechanism of action of selamectin involves binding to glutamate-gated chloride channels in the nerve and muscle cells of parasites. This binding causes increased chloride ion permeability, resulting in hyperpolarization of cell membranes, paralysis, and death of the parasite. The selectivity of this mechanism for invertebrate-specific receptors provides excellent safety for mammalian hosts including guinea pigs. After topical application to the skin, selamectin is absorbed into the bloodstream and distributed throughout the body, providing systemic activity against parasites that feed on blood or tissue fluids while also concentrating in the skin and hair follicles.

Selamectin is available as a spot-on solution in single-dose applicator tubes containing various concentrations designed for different sized animals. For guinea pig use, the puppy/kitten formulation containing 15 mg selamectin per tube is most commonly used, as it provides an appropriate concentration for small exotic mammals. The single-tube format allows precise dosing when divided appropriately based on guinea pig body weight, with the exotic veterinarian calculating the specific amount needed for each patient. The topical application method eliminates the stress of injections while providing systemic medication delivery.

The safety profile of selamectin in guinea pigs is excellent when the medication is used according to exotic veterinary guidance. Studies and clinical experience have demonstrated good tolerance of appropriate doses in guinea pigs of various ages and sizes. The topical application avoids gastrointestinal exposure that could disrupt the sensitive guinea pig gut flora. Selamectin provides residual activity for several weeks after application, reducing the frequency of treatments needed compared to some other antiparasitic options. This extended duration of action simplifies treatment protocols and improves owner compliance.

The primary indication for selamectin in guinea pigs is the treatment of lice infestations caused by Gliricola porcelli and Gyropus ovalis, the species-specific chewing and sucking lice that parasitize cavies. These ectoparasites cause intense pruritus, excessive scratching, hair loss, skin irritation, and significant distress in affected guinea pigs. Lice infestations can occur in guinea pigs from any background but are particularly common in newly acquired animals and those from crowded environments. Selamectin provides highly effective treatment, eliminating lice populations through systemic activity that reaches parasites wherever they feed on the guinea pig's body.

The systemic distribution of selamectin after topical application provides comprehensive coverage against lice regardless of their location on the guinea pig. Unlike purely topical treatments that must physically contact each parasite, selamectin reaches lice when they feed, ensuring treatment of parasites in areas difficult to access with direct application such as around the face, ears, and in dense fur folds. This complete body coverage makes selamectin particularly valuable for guinea pigs with heavy infestations affecting multiple body regions and for guinea pigs whose temperament makes thorough topical treatment application challenging.

Secondary uses of selamectin in guinea pigs include treatment of various mite species that commonly infest these animals. Sarcoptic mange mites (Trixacarus caviae), which cause severe itching and characteristic crusty skin lesions, respond well to selamectin treatment. Fur mites (Chirodiscoides caviae) and other surface-dwelling mites are also effectively eliminated. The broad-spectrum activity against multiple ectoparasite species makes selamectin an excellent choice when the specific parasite causing infestation has not been definitively identified or when mixed infestations involving multiple parasite species are present.

Additional clinical applications of selamectin include preventive treatment during introduction of new guinea pigs to established groups and prophylactic use in high-risk situations. Treating new arrivals during quarantine addresses any parasites they may be carrying before introduction to resident guinea pigs. Some rescue organizations and breeders incorporate selamectin into intake protocols for consistent parasite prevention. The residual activity of selamectin provides several weeks of protection, making it suitable for preventive as well as therapeutic applications.

Selamectin is selected over alternative lice treatments for several reasons specific to guinea pig practice. The topical spot-on application is less stressful than injections for many guinea pigs and their owners. The residual activity of four to six weeks means fewer treatments are needed compared to products requiring weekly application. The broad spectrum covers both lice and mites, simplifying treatment when the specific diagnosis is uncertain. The established safety record in guinea pigs provides confidence in prescribing. For guinea pigs with confirmed lice infestations, selamectin offers an excellent combination of efficacy, safety, and convenience.

Selamectin dosing in guinea pigs is calculated based on body weight, with the exotic veterinarian determining the specific dose for each patient. Guinea pigs should be accurately weighed in grams using a reliable scale immediately before treatment, as dosing calculations depend on current body weight. The generally accepted dose range is 15 to 20 mg/kg applied topically, though your veterinarian may adjust this based on the specific product available and individual patient factors. The puppy/kitten Revolution formulation (15 mg per 0.25 ml tube) is commonly used for guinea pig dosing, with the volume applied calculated from the guinea pig's weight.

The typical treatment protocol for lice involves application of selamectin at the appropriate dose, repeated once in two to four weeks to address the parasite life cycle. Because selamectin has residual activity lasting several weeks, fewer treatments are typically needed compared to medications requiring more frequent application. For heavy infestations or persistent problems, a third dose may be administered. The exotic veterinarian determines the specific treatment schedule based on infestation severity, response to initial treatment, and individual patient factors.

Treatment duration depends on the severity of infestation and clinical response. Most guinea pigs show improvement in scratching behavior within one to two weeks of the first application as the lice population decreases. Complete resolution typically occurs by the end of the treatment course. Follow-up examination by the exotic veterinarian after completing treatment confirms successful elimination and determines whether additional doses are needed. Environmental treatment through thorough bedding cleaning should continue throughout the treatment period.

Administration technique for selamectin requires parting the fur to expose the skin, typically at the back of the neck between the shoulder blades where the guinea pig cannot easily groom. The medication is applied directly to the skin, not just to the fur. The spot-on applicator is held vertically and gently squeezed to dispense the calculated dose onto the exposed skin in one spot or divided between two spots if the volume is larger. Avoid applying to broken or irritated skin. The application site should not be rubbed or manipulated after application to allow proper absorption.

If a scheduled treatment is missed, apply it as soon as remembered and then continue the treatment schedule from that date, maintaining the recommended interval before subsequent doses. Do not double the dose to make up for missed treatments. Contact the exotic veterinarian if significant delays occur for guidance on adjusting the treatment protocol.

Completing the full treatment course is essential for successful lice elimination even if visible parasites disappear after the first dose. The treatment protocol is designed to address the parasite life cycle, including parasites that may hatch from eggs after initial treatment. Stopping treatment early commonly results in reinfestation from surviving parasites or eggs. Environmental treatment with thorough cage cleaning and hot washing of fabric bedding should coincide with each selamectin application to eliminate environmental parasite reservoirs.

Selamectin is remarkably well-tolerated in guinea pigs when administered at appropriate doses, with side effects being uncommon in routine clinical use. The favorable safety profile has been demonstrated through years of off-label use in exotic practice. Most guinea pigs complete their treatment course without any noticeable adverse effects beyond possible minor local reactions. Understanding potential side effects helps owners monitor treated guinea pigs appropriately and recognize any issues requiring veterinary attention.

The most commonly observed effects relate to the application site rather than systemic medication effects. Temporary hair loss or change in fur texture at the application site occurs in some guinea pigs, typically resolving as new fur grows. Minor skin irritation with slight redness at the application site has been reported but usually resolves within a few days. Some guinea pigs may show behavioral response to the wet sensation of the medication, including head shaking or attempts to reach the application area. These local reactions are generally mild and self-limiting.

Moderate side effects are uncommon but may include temporary lethargy or decreased activity in the 24 to 48 hours following application. Some guinea pigs show reduced appetite on the day of treatment, which should normalize by the following day. Salivation may occur if the guinea pig manages to groom the application site before the medication fully absorbs and dries. Mild gastrointestinal changes such as slightly soft stools have been occasionally reported. Any appetite reduction lasting more than 24 hours warrants veterinary consultation, as guinea pigs cannot tolerate extended periods without eating.

Serious side effects from selamectin are rare in guinea pigs receiving appropriate doses. Signs suggesting significant adverse reaction include severe lethargy or weakness, tremors or muscle twitching, incoordination or difficulty walking, excessive salivation, or seizures. These neurological signs would indicate possible toxicity and require immediate veterinary attention. Severe local reactions with significant swelling, ulceration, or evidence of allergic response at the application site also warrant prompt evaluation. The wide margin of safety in guinea pigs makes serious reactions uncommon with properly calculated doses.

Rare idiosyncratic reactions may occur in individual guinea pigs even at appropriate doses. Some guinea pigs may display hypersensitivity to selamectin or inactive ingredients in the formulation. Allergic-type reactions with facial swelling, respiratory changes, or generalized hives would require immediate veterinary care and preclude future use of selamectin in that individual. If any concerning symptoms develop following selamectin application, contact the exotic veterinarian for evaluation and guidance.

Selamectin is contraindicated in guinea pigs with known hypersensitivity or previous adverse reaction to selamectin, other avermectin/milbemycin class drugs including ivermectin and moxidectin, or any inactive ingredients in the Revolution formulation. True allergic reactions to macrocyclic lactones are rare but documented, and any guinea pig experiencing a significant adverse event following previous exposure should not receive the medication again. Alternative antiparasitic treatments from different drug classes can be discussed with the exotic veterinarian for guinea pigs unable to receive selamectin safely.

Application to broken, irritated, or diseased skin represents a contraindication for selamectin use. Damaged skin may allow increased absorption potentially leading to higher systemic drug levels than intended. Guinea pigs with significant skin lesions from severe scratching, secondary bacterial infections, or open wounds at the standard application site should have the skin condition addressed before selamectin application, or an alternative application site with intact skin should be selected. The exotic veterinarian can assess skin condition and determine appropriate treatment approach.

Very young guinea pigs under three weeks of age should not receive selamectin due to their immature organ systems and developing metabolic capacity. While selamectin has good safety margins, the pharmacokinetics in very young animals may differ from adults, and safety in this age group has not been established. Nursing pups may receive indirect exposure through the milk if their mother is treated, which should be considered when treating nursing sows. Delaying treatment until pups are weaned is often preferred when possible.

Pregnant guinea pigs require careful consideration before selamectin treatment. While reproductive toxicity studies in dogs and cats did not demonstrate significant concerns, effects in pregnant guinea pigs have not been specifically studied. The exotic veterinarian weighs the risks of untreated parasitic infestation against theoretical medication risks when making treatment decisions for pregnant animals. Many veterinarians will treat pregnant guinea pigs with selamectin when parasite infestation is causing significant distress, as the stress of infestation may itself pose pregnancy risks.

Severely debilitated guinea pigs may require stabilization before antiparasitic treatment. Guinea pigs that are critically ill, severely underweight, or experiencing other serious health issues may benefit from supportive care before introducing additional medications. However, parasitic infestations contribute to debilitation, so treatment decisions must balance the need for supportive care against the ongoing impact of untreated parasites. The exotic veterinarian evaluates the complete clinical picture when determining treatment timing.

Selamectin has a relatively favorable drug interaction profile compared to many other medications, but several important considerations apply when using this antiparasitic in guinea pigs receiving other treatments. Complete disclosure of all medications, supplements, and topical products currently used for the guinea pig ensures the exotic veterinarian can prescribe safely and avoid potential interactions.

The most significant interaction category involves P-glycoprotein inhibitors, which can increase selamectin penetration into the central nervous system and potentially cause neurotoxicity. Certain drugs inhibit the P-glycoprotein transport protein that normally helps exclude selamectin from the brain. While guinea pigs are unlikely to receive many of the medications known to inhibit P-glycoprotein, any concurrent medication should be discussed with the exotic veterinarian. Spinosad, used in some flea products for dogs and cats, is a known P-glycoprotein inhibitor that should not be used in combination with selamectin.

Concurrent use of other antiparasitic medications requires coordination to avoid both duplicate treatment and potential additive effects. If selamectin is being combined with other treatments such as pyrethrin sprays for rapid knockdown of heavy infestations, the timing and products should be coordinated through the exotic veterinarian. Using multiple macrocyclic lactones simultaneously, such as selamectin plus ivermectin, would be inappropriate as they share mechanisms and could cause toxicity. The exotic veterinarian can design combination protocols that maximize efficacy while maintaining safety.

Topical products applied near the selamectin application site could potentially affect absorption or cause local reactions. Avoid applying other topical medications, conditioners, or treatments to the selamectin application area until the medication has fully absorbed and dried, typically several hours after application. If multiple topical products are needed for the guinea pig's condition, spacing applications by at least 24 hours or using different body locations helps prevent interactions.

No significant interactions have been documented between selamectin and vitamin C supplementation or other common guinea pig dietary supplements. Vitamin C should continue throughout treatment at the normal supplementation level of 50 to 100 mg daily. Probiotic supplements may be continued as well. Maintaining normal nutrition and supplementation supports overall guinea pig health during parasite treatment and recovery.

General precautions for selamectin use in guinea pigs begin with ensuring accurate weight measurement for proper dosing. Guinea pigs should be weighed in grams on a reliable scale immediately before treatment. Significant weight changes between treatments may require dose recalculation. Using the correct selamectin product formulation, typically the puppy/kitten version for guinea pigs, prevents dosing errors that could occur with higher concentration products designed for larger animals.

Application technique precautions ensure proper drug delivery and minimize complications. Part the fur adequately to expose the skin before applying the medication directly to the skin rather than onto the fur. The recommended application site between the shoulder blades at the base of the skull minimizes the guinea pig's ability to groom and ingest the medication. Apply the medication to intact, healthy skin rather than irritated or damaged areas. Avoid allowing the medication to run off the application site; if the volume is large, dividing between two adjacent spots improves absorption.

Post-application precautions reduce the risk of medication ingestion and optimize absorption. Do not bathe the guinea pig or wet the application site for at least 48 hours after application to allow complete absorption. In multi-guinea pig households, treated animals should be separated from untreated cage mates until the application site is dry to prevent mutual grooming of the medication. Monitor the guinea pig for any attempts to groom the application site and redirect if observed during the initial hours after application.

Monitoring during treatment allows early detection of both treatment response and potential adverse effects. Check the guinea pig daily for reduction in scratching behavior, improvement in coat condition, and resolution of any visible parasites. Normal appetite, activity level, and fecal output indicate good tolerance of the medication. Any abnormalities should be reported to the exotic veterinarian. Follow-up examination after completing the treatment course confirms successful parasite elimination.

Special population precautions apply to guinea pigs at higher risk for altered drug responses. Senior guinea pigs over three to four years may have reduced liver and kidney function affecting drug metabolism. Young guinea pigs under eight weeks require careful dosing based on their smaller body weight. Guinea pigs with liver or kidney disease may process selamectin differently. The exotic veterinarian considers these factors when prescribing and may recommend modified protocols for special populations.

Selamectin products should be stored according to manufacturer directions to maintain medication potency and safety. Revolution spot-on tubes should be stored at controlled room temperature, typically between 59 and 86 degrees Fahrenheit (15 to 30 degrees Celsius). The product should be kept in its original packaging, which provides protection from light and helps identify the product and its concentration. Storage areas should be dry and secure, completely inaccessible to guinea pigs, other pets, and children. Avoid storing selamectin in areas subject to temperature extremes or high humidity.

Individual dose tubes should remain sealed in their foil packaging until ready for use. Once the foil pouch is opened and the tube cap removed, the medication should be used promptly rather than stored for later application. Partially used tubes should not be saved for future treatments, as contamination and degradation concerns make re-use inappropriate. The exotic veterinarian may provide specific guidance on handling tubes that contain more medication than needed for a single guinea pig dose, though typically partial tubes should be discarded after use.

Safe handling practices protect household members during storage and application. While selamectin has relatively low mammalian toxicity, direct contact with skin or eyes should be avoided. Wash hands thoroughly after handling the medication. If accidental skin contact occurs, wash the area with soap and water. If the product contacts eyes, flush immediately with water and seek medical attention if irritation persists. Do not eat, drink, or smoke while handling selamectin. Keep the product away from face during application.

Disposal of selamectin products should follow local guidelines for pharmaceutical waste. Empty tubes should be disposed of according to local regulations rather than recycled. Unused or expired products should not be disposed of through household drains or regular trash if local guidelines prohibit this. Drug take-back programs or community hazardous waste collection provide appropriate disposal options in many areas. The medication's environmental toxicity to aquatic organisms makes proper disposal important. Foil packaging and any contaminated materials should be disposed of with the product.

All guinea pig breeds respond similarly to selamectin treatment for lice infestations, with the medication's systemic mechanism of action working effectively regardless of breed characteristics. The transdermal absorption and body-wide distribution ensure consistent treatment regardless of fur type or density. However, certain breed-related factors influence application technique and monitoring considerations, making awareness of breed characteristics valuable for optimal treatment outcomes.

Skinny pigs and Baldwin guinea pigs, the hairless and nearly hairless varieties, present modified considerations for topical selamectin application. Without fur to part, application to these breeds is more straightforward in terms of accessing the skin. However, the lack of fur means the medication sits directly on bare skin rather than being somewhat protected within a fur layer. This direct skin contact does not typically cause problems but warrants closer monitoring for local reactions. Additionally, without fur to absorb some of the applied solution, hairless guinea pigs may show more visible residue at the application site until absorption is complete.

Long-haired breeds including Peruvian, Silkie, Texel, Lunkarya, and Coronet guinea pigs require extra attention during application to ensure the medication reaches the skin rather than remaining on the fur surface. The dense, long coat must be carefully parted to expose the skin at the application site. Applying medication to fur rather than skin significantly reduces absorption and treatment efficacy. After application, the long coat provides protection over the application site, potentially reducing the guinea pig's ability to groom the area compared to short-coated breeds. However, the extended drying time within thick fur should be considered when determining when it is safe to house treated guinea pigs with untreated companions.

Size variations among guinea pig breeds and individuals directly affect dosing calculations. Larger guinea pigs such as adult Rex or some American bloodlines require proportionally larger doses based on their body weight. Smaller individuals need precisely calculated smaller amounts. The importance of accurate weighing in grams applies universally but becomes particularly critical at size extremes where relative dosing errors have proportionally greater impact. The exotic veterinarian uses actual body weight rather than breed average weights for dose calculation.

Age-related considerations apply across all breeds equally. Young guinea pigs under three weeks should not receive selamectin. Elderly guinea pigs may have reduced organ function affecting drug processing. These factors are considered by the exotic veterinarian when developing treatment protocols for guinea pigs at any age extreme, regardless of breed.

Within the same macrocyclic lactone drug class, ivermectin represents the most commonly used alternative to selamectin for guinea pig lice treatment. Ivermectin can be administered via subcutaneous injection or orally, providing options when topical application is impractical or when owners prefer injectable treatment. Both medications share the same mechanism of action and similar efficacy against lice and mites. Ivermectin has a longer history of use in guinea pigs and may be more cost-effective in some situations. Moxidectin is another macrocyclic lactone used in some exotic practices, though its use in guinea pigs is less established than either selamectin or ivermectin.

Different drug class alternatives provide options when macrocyclic lactones are contraindicated or have failed. Pyrethrin-based products offer topical treatment through a different mechanism targeting sodium channels in parasites. While pyrethrins provide rapid knockdown of active parasites, they lack the residual activity of selamectin and require more frequent application. Fipronil, widely used in dogs and cats, is generally avoided in guinea pigs due to safety concerns. Alternative options are limited, making selamectin and ivermectin the preferred treatments in most guinea pig practices.

Complementary therapies enhance treatment success and should be incorporated into comprehensive lice management protocols. Environmental treatment is essential regardless of which medication is used for direct treatment of the guinea pig. High-temperature washing of fabric bedding, thorough cage cleaning, and treatment of surrounding areas eliminate environmental parasite reservoirs. Treating all guinea pigs in a household simultaneously prevents untreated animals from serving as ongoing sources of infestation. Vitamin C supplementation supports immune function during the stress of infestation and treatment. Maintaining optimal nutrition and reducing environmental stressors promotes recovery. If secondary skin infections have developed from scratching, additional treatments may be needed. The exotic veterinarian coordinates all aspects of treatment to ensure a comprehensive approach addressing both the parasites and any associated complications.